The article profiles the Ammortal Chamber, a luxury wellness device priced at $159,500 that is marketed as a tool for recovery, stress reduction and longevity rather than a medical treatment. Framed through a first-person visit to an upscale Connecticut med spa, the piece explores how the machine fits into a wider culture of affluent wellness and biohacking, where people are increasingly willing to try expensive, technology-driven methods to manage ageing and optimise health. Its significance lies less in proven immortality than in what it reveals about the growing commercial market for longevity products and the celebrity attention helping to legitimise them.

The chamber, released in 2023, combines several non-invasive features including meditation, molecular hydrogen, vibroacoustics, electromagnetics, red light therapy and near-infrared therapy. Its creator, Brian Le Gette, is careful not to present it as a device that heals or cures, saying instead that it is intended to support the body’s own recovery by helping shift users into a calmer parasympathetic state. The article notes endorsements and reported use by high-profile athletes including Matthew Stafford, Mike Trout and Freddie Freeman, while placing the machine alongside other fashionable treatments mentioned at the spa, such as NAD+ infusions and salmon-DNA-based PDRN injections.